Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands.
Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands.
Am J Hematol. 2017 Oct;92(10):E584-E590. doi: 10.1002/ajh.24855. Epub 2017 Jul 29.
Organ damage in sickle cell disease (SCD) is a crucial determinant for disease severity and prognosis. In a previous study, we analyzed the prevalence of SCD-related organ damage and complications in adult sickle cell patients. We now describe a seven-year follow-up of this cohort.All patients from the primary analysis in 2006 (n = 104), were included for follow-up. Patients were screened for SCD-related organ damage and complications (microalbuminuria, renal failure, elevated tricuspid regurgitation flow velocity (TRV) (≥2.5 m/seconds), retinopathy, iron overload, cholelithiasis, avascular osteonecrosis, leg ulcers, acute chest syndrome (ACS), stroke, priapism and admissions for vaso-occlusive crises (VOC) biannually. Upon 7 years of follow-up, progression in the prevalence of avascular osteonecrosis (from 12.5% to 20.4%), renal failure (from 6.7% to 23.4%), retinopathy (from 39.7% to 53.8%) was observed in the whole group. In HbSS/HbSβ -thal patients also progression in microalbuminuria (from 34% to 45%) and elevated TRV (from 40% to 48%) was observed while hardly any progression in the prevalence of cholelithiasis, priapism, stroke or chronic ulcers was seen. The proportion of patients with at least one episode of ACS increased in the group of HbSS/HbSβ -thal patients from 32% to 49.1%. In conclusion, 62% of the sickle cell patients in this prospective cohort study developed a new SCD-related complication in a comprehensive care setting within 7 years of follow-up. Although the hospital admission rate for VOC remained stable, multiple forms of organ damage increased substantially. These observations underline the need for continued screening for organ damage in all adult patients with SCD.
镰状细胞病(SCD)中的器官损伤是决定疾病严重程度和预后的关键因素。在之前的研究中,我们分析了成年镰状细胞患者中与 SCD 相关的器官损伤和并发症的患病率。现在我们描述了该队列的七年随访结果。所有来自 2006 年主要分析的患者(n=104)均被纳入随访。对患者进行了与 SCD 相关的器官损伤和并发症(微量白蛋白尿、肾衰竭、三尖瓣反流流速升高(TRV)(≥2.5m/秒)、视网膜病变、铁过载、胆石症、缺血性骨坏死、腿部溃疡、急性胸部综合征(ACS)、中风、阴茎异常勃起和血管阻塞性危象(VOC)入院)的筛查,每两年一次。在 7 年的随访中,整个组中缺血性骨坏死(从 12.5%到 20.4%)、肾衰竭(从 6.7%到 23.4%)和视网膜病变(从 39.7%到 53.8%)的患病率均有进展。在 HbSS/HbSβ-thal 患者中,微量白蛋白尿(从 34%到 45%)和 TRV 升高(从 40%到 48%)的患病率也有所进展,而胆石症、阴茎异常勃起、中风或慢性溃疡的患病率几乎没有进展。在 HbSS/HbSβ-thal 患者组中,至少有一次 ACS 发作的患者比例从 32%增加到 49.1%。总之,在这项前瞻性队列研究中,62%的镰状细胞患者在 7 年的随访期间在综合护理环境中出现了新的与 SCD 相关的并发症。尽管 VOC 的住院入院率保持稳定,但多种形式的器官损伤显著增加。这些观察结果强调了在所有成年 SCD 患者中继续进行器官损伤筛查的必要性。